Prostaglandin and prostaglandin receptors: present and future promising therapeutic targets for pulmonary arterial hypertension

BACKGROUND: Pulmonary arterial hypertension (PAH), Group 1 pulmonary hypertension (PH), is a type of pulmonary vascular disease characterized by abnormal contraction and remodeling of the pulmonary arterioles, manifested by pulmonary vascular resistance (PVR) and increased pulmonary arterial pressur...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Cheng, Liu, Jing, Zheng, Xialei, Hu, Xinqun, He, Yuhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619262/
https://www.ncbi.nlm.nih.gov/pubmed/37915044
http://dx.doi.org/10.1186/s12931-023-02559-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619262/
https://www.ncbi.nlm.nih.gov/pubmed/37915044
http://dx.doi.org/10.1186/s12931-023-02559-3

Ejemplares similares